The Aprepitant Injection Market growth continues to accelerate as oncology supportive care and anesthesia protocols increasingly prioritize effective antiemetic management for improved patient outcomes. With chemotherapy-induced nausea and vomiting (CINV) remaining one of the most distressing adverse effects of cancer treatment, and postoperative nausea and vomiting (PONV) significantly...